Mission
At DeepOMAP, we're committed to transforming cancer diagnosis and treatment by reducing turnaround times from weeks to mere hours. Powered by cutting-edge AI and single-cell sequencing, our platform delivers early, accurate predictions of drug resistance—empowering oncologists to make timely, life-saving decisions. Rooted in Maine, our interdisciplinary team innovates solutions that overcome the unique challenges of rural healthcare, bringing advanced precision diagnostics directly to those who need them most.
Detection Accuracy
Faster Diagnosis
Leadership
Our multidisciplinary team combines expertise in oncology, artificial intelligence, and software engineering.
Foundational AI Model
DeepOMAP's platform analyzes single-cell multi omics datasets to predict progression, and recommend personalized treatments.
Key Features
Advanced Detection
Identify early-stage tumors with 94% accuracy
Treatment Recommendations
AI-assisted personalized treatment planning
Progression Analysis
Predict cancer progression pathways
Integration
Seamless workflow with existing hospital systems
Our Journey
DeepOMAP Founded
Registered as Maine-based LLC
Selected for MIT NSF I-Corps Program
Customer discovery and validation
Developed initial prototype and conducted user interviews.
Early Minimum Viable Product (MVP) Launched
Validating and improving AI algorithms
Developed initial foundational model for cancer detection and explainable AI.
Get In Touch
Contact Us
Interested in learning more about DeepOMAP? find us at the Vanaja Lab at the Roux Institute, Northeastern University, Portland, Maine.
Vanaja Lab